Skip to main content
. 2021 Aug 17;11:16691. doi: 10.1038/s41598-021-96300-z

Figure 1.

Figure 1

Workflow of the current study. We used 2 cohorts: a derivation cohort including cross-sectional subjects and a validation cohort including longitudinal subjects treated by TCZ. In the derivation cohort, we measured gene expression according to cell subpopulations and summarized all CD4+ T cells and CD8+ T cells in the expression analysis. HC, healthy control; IFX, infliximab; MTX, methotrexate; RA, rheumatoid arthritis; NT, non-treatment; TCM, central memory T cell; TCZ, tocilizumab; TEM, effector memory T cell; TEMRA, CD45RA-positive effector memory T cell; TN, naïve T cell.